Global Hunter Securities Downgrades Pharmacyclics (PCYC) to Neutral; Enters Global Partnership with JNJ for Btk-inhibitor PCI-32765

Go back to Global Hunter Securities Downgrades Pharmacyclics (PCYC) to Neutral; Enters Global Partnership with JNJ for Btk-inhibitor PCI-32765